This startup will leverage AI to analyze data from exceptional cancer survivors, identifying unique biological markers, lifestyle factors, and treatment responses that contribute to their resilience. The platform will then use this information to develop personalized risk assessments and preventative strategies for individuals at high risk of developing cancer, or those seeking to improve their long-term health outcomes post-treatment. It addresses the “white space” in oncology by moving beyond average patient outcomes to focus on outlier success stories.